AMGEN INC is 132.0x more valuable than Vir Biotechnology, Inc. by market capitalization ($191.70 B vs $1.45 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VIR | AMGN |
|---|---|---|
| Market cap | $1.45 B | $191.70 B |
| US-listed rank | #2370 | #79 |
| Revenue (latest FY) | $68.56M | $36.75B |
| Net income (latest FY) | -$437.99M | $7.71B |
| Net margin | -638.9% | 21.0% |
| P/E (trailing FY) | - | 24.9 |
| SEC filings | 762 | 1,011 |
AMGEN INC is 132.0x more valuable than Vir Biotechnology, Inc. by market capitalization ($191.70 B vs $1.45 B).
In their latest fiscal years, Vir Biotechnology, Inc. reported $68.56M in revenue while AMGEN INC reported $36.75B.
Full pages: Vir Biotechnology, Inc. and AMGEN INC, or browse the full rankings.